Literature DB >> 16042909

Symptom overlap and comorbidity of irritable bowel syndrome with other conditions.

Christine L Frissora1, Kenneth L Koch.   

Abstract

Irritable bowel syndrome (IBS) is one of several highly prevalent, multi-symptom gastrointestinal motility disorders that have a wide clinical spectrum and are associated with symptoms of gastrointestinal dysmotility and visceral hypersensitivity. Symptom overlap and comorbidity between IBS and other gastrointestinal motility disorders (eg, chronic constipation, functional dyspepsia, gastroesophageal reflux disease), with gastrointestinal disorders that are not related to motility (eg, celiac disease, lactose intolerance), and with somatic conditions (eg, fibromyalgia, chronic fatigue syndrome), are frequent. The clinical associations and pathophysiologic links between IBS and these disorders continue to be explored. This review discusses overlapping symptoms and comorbidity of IBS with select gastrointestinal and non-gastrointestinal disorders and attempts to identify commonalities among these conditions.

Entities:  

Mesh:

Year:  2005        PMID: 16042909     DOI: 10.1007/s11894-005-0018-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  78 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 2.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 3.  Chronic constipation.

Authors:  Anthony Lembo; Michael Camilleri
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

4.  Lactose malabsorption and IBS.

Authors:  R Montes; E Monge
Journal:  Scand J Gastroenterol       Date:  2004-10       Impact factor: 2.423

Review 5.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

6.  Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?

Authors:  G Holtmann; H Goebell; N J Talley
Journal:  Am J Gastroenterol       Date:  1997-06       Impact factor: 10.864

Review 7.  A review of the evidence for overlap among unexplained clinical conditions.

Authors:  L A Aaron; D Buchwald
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

8.  Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption.

Authors:  Mark Pimentel; Yuthana Kong; Sandy Park
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

9.  Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study.

Authors:  P G Farup; K W Monsbakken; P O Vandvik
Journal:  Scand J Gastroenterol       Date:  2004-07       Impact factor: 2.423

Review 10.  Gluten-sensitive enteropathy (celiac disease): more common than you think.

Authors:  David A Nelsen
Journal:  Am Fam Physician       Date:  2002-12-15       Impact factor: 3.292

View more
  36 in total

1.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

2.  Acute abdominal pain in irritable bowel syndrome patients: not always an acute exacerbation.

Authors:  Vui Heng Chong; Chean Leung Chong
Journal:  Dig Dis Sci       Date:  2007-03-15       Impact factor: 3.199

3.  Diagnosing small bowel malabsorption.

Authors:  Dino Vaira
Journal:  Intern Emerg Med       Date:  2013-11-30       Impact factor: 3.397

4.  Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?

Authors:  Michael Camilleri
Journal:  Am J Gastroenterol       Date:  2012-03       Impact factor: 10.864

5.  Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation.

Authors:  Meagan M Costedio; Matthew D Coates; Elice M Brooks; Lisa M Glass; Eric K Ganguly; Hagen Blaszyk; Allison L Ciolino; Michael J Wood; Doris Strader; Neil H Hyman; Peter L Moses; Gary M Mawe
Journal:  Am J Gastroenterol       Date:  2009-12-15       Impact factor: 10.864

6.  Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study.

Authors:  Khaled Ali Jadallah; Yousef Saleh Khader
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

7.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

8.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 9.  Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.

Authors:  Xiaomei Cong; Mallory Perry; Katherine M Bernier; Erin E Young; Angela Starkweather
Journal:  West J Nurs Res       Date:  2017-08-30       Impact factor: 1.967

Review 10.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.